HomeNewsBusinessCovid-19: IT firms cash in on back-to-work solutions as enterprises look to get going again

Covid-19: IT firms cash in on back-to-work solutions as enterprises look to get going again

Top IT firms such as HCL Tech, Infosys, and TCS have launched solutions internally as well as for their customers to cater to changing safety protocols amid the Covid pandemic

September 23, 2020 / 13:26 IST
Story continues below Advertisement

From ensuring physical distancing to carrying out temperature checks to instituting contactless attendance, Indian IT firms are cashing in on the rising demand for safe work solutions among enterprise customers worldwide.

Though these solutions earn only modest revenue for IT firms, they help build relationships with customers during crises, say analysts.

Story continues below Advertisement

Over the last few months, Indian IT firms have launched a range of solutions that will help companies get their employees back to work safely. The focus obviously is on ensuring physical distancing and other safety protocols are followed and maintained.

These companies include top IT firms such as HCL Tech, Infosys, and TCS, which have launched solutions internally as well as for their customers, to cater to changing safety protocols amid the Covid pandemic.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show